Literature DB >> 3303476

Infection and disease due to the environmental mycobacteria.

J M Grange.   

Abstract

Saprophytic mycobacteria are widely distributed in the environment and contact between them and man is unavoidable. Immunologically effective contact is responsible for cross-reactivity to tuberculin and there is increasing evidence that it also profoundly affects the nature of subsequent responses to BCG vaccination and to infection by the tubercle and leprosy bacilli. Some environmental mycobacteria occasionally cause overt disease. Two species, Mycobacterium ulcerans and M. marinum, cause characteristic named diseases: Buruli ulcer and swimming pool granuloma respectively. Other species cause pulmonary and non-pulmonary lesions that resemble those of tuberculosis. Disease often, but not always, occurs in individuals with predisposing factors such as damaged lungs or immunosuppressive disorders including AIDS. Diagnosis rests on the isolation and identification of the causative species and treatment is based on antituberculous therapy for extended periods or combinations of various other drugs. In contrast to tuberculosis, the incidence of these diseases appears to be on the increase in the Western world and they merit serious consideration.

Entities:  

Mesh:

Year:  1987        PMID: 3303476     DOI: 10.1016/0035-9203(87)90206-9

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  9 in total

Review 1.  Agents of newly recognized or infrequently encountered mycobacterial diseases.

Authors:  L G Wayne; H A Sramek
Journal:  Clin Microbiol Rev       Date:  1992-01       Impact factor: 26.132

Review 2.  Antigens of the Mycobacterium avium, Mycobacterium intracellulare complex.

Authors:  S L Morris
Journal:  Eur J Epidemiol       Date:  1991-07       Impact factor: 8.082

3.  Evaluation of the recombinant 38-kilodalton antigen of Mycobacterium tuberculosis as a potential immunodiagnostic reagent.

Authors:  R J Wilkinson; K Hasløv; R Rappuoli; F Giovannoni; P R Narayanan; C R Desai; H M Vordermeier; J Paulsen; G Pasvol; J Ivanyi; M Singh
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

4.  Isolation, PCR based identification, and sensitivity pattern of environmental mycobacteria from leprosy and tuberculosis patients.

Authors:  D Saravanakumar; N Elangeswaran; S Senthilkumar; G Vanaja; S Kamakshiammal; C Chandrasekar; C N Deivanayagam; M Sritharan; V Sritharan
Journal:  Indian J Clin Biochem       Date:  2000-07

5.  Iatrogenic outbreak of M. chelonae skin abscesses.

Authors:  D Camargo; C Saad; F Ruiz; M E Ramirez; M Lineros; G Rodriguez; E Navarro; B Pulido; L C Orozco
Journal:  Epidemiol Infect       Date:  1996-08       Impact factor: 2.451

6.  Responses to tuberculin among Zebu cattle in the transhumance regions of Karamoja and Nakasongola district of Uganda.

Authors:  J Oloya; J Opuda-Asibo; B Djønne; J B Muma; G Matope; R Kazwala; E Skjerve
Journal:  Trop Anim Health Prod       Date:  2006-05       Impact factor: 1.559

7.  Comparison of the abilities of Mycobacterium avium and Mycobacterium intracellulare to infect and multiply in cultured human macrophages from normal and human immunodeficiency virus-infected subjects.

Authors:  A J Crowle; E R Ross; D L Cohn; J Gilden; M H May
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

Review 8.  Mycobacterial disease, immunosuppression, and acquired immunodeficiency syndrome.

Authors:  F M Collins
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

9.  CD1b-mediated T cell recognition of a glycolipid antigen generated from mycobacterial lipid and host carbohydrate during infection.

Authors:  D B Moody; M R Guy; E Grant; T Y Cheng; M B Brenner; G S Besra; S A Porcelli
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.